HCP Live December 15, 2023
Kevin Kunzmann

Califf joins HCPLive to share perspective on AI, gene and cell therapy development, COVID-19, food and substance regulation, maternal and infant health, weight loss intervention, and more.

Since 2017, HCPLive has published hundreds of end-of-year feature articles and multimedia reviews as part of the annual This Year in Medicine series. Over those 7 years, the most returned-to subjects by our staff and clinician experts alike have pertained to key decisions from the US Food and Drug Administration (FDA): more often than not, when a specialist is asked, ‘What was the biggest news in your field this year?’ their mind goes to practice-changing drug approval or regulatory decisions. Just read our advisory board’s top story picks this year to see for...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Trends
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article